1. Home
  2. CTS vs STOK Comparison

CTS vs STOK Comparison

Compare CTS & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTS
  • STOK
  • Stock Information
  • Founded
  • CTS 1896
  • STOK 2014
  • Country
  • CTS United States
  • STOK United States
  • Employees
  • CTS N/A
  • STOK N/A
  • Industry
  • CTS Electrical Products
  • STOK Biotechnology: Pharmaceutical Preparations
  • Sector
  • CTS Technology
  • STOK Health Care
  • Exchange
  • CTS Nasdaq
  • STOK Nasdaq
  • Market Cap
  • CTS 1.2B
  • STOK 1.3B
  • IPO Year
  • CTS N/A
  • STOK 2019
  • Fundamental
  • Price
  • CTS $42.07
  • STOK $31.97
  • Analyst Decision
  • CTS
  • STOK Strong Buy
  • Analyst Count
  • CTS 0
  • STOK 7
  • Target Price
  • CTS N/A
  • STOK $30.83
  • AVG Volume (30 Days)
  • CTS 212.2K
  • STOK 1.5M
  • Earning Date
  • CTS 10-28-2025
  • STOK 11-12-2025
  • Dividend Yield
  • CTS 0.38%
  • STOK N/A
  • EPS Growth
  • CTS 18.55
  • STOK N/A
  • EPS
  • CTS 2.11
  • STOK 0.91
  • Revenue
  • CTS $520,937,000.00
  • STOK $199,893,000.00
  • Revenue This Year
  • CTS $3.90
  • STOK $416.54
  • Revenue Next Year
  • CTS $6.50
  • STOK N/A
  • P/E Ratio
  • CTS $19.97
  • STOK $35.55
  • Revenue Growth
  • CTS 1.12
  • STOK 1218.82
  • 52 Week Low
  • CTS $34.02
  • STOK $5.35
  • 52 Week High
  • CTS $59.68
  • STOK $38.69
  • Technical
  • Relative Strength Index (RSI)
  • CTS 58.69
  • STOK 62.96
  • Support Level
  • CTS $40.81
  • STOK $31.19
  • Resistance Level
  • CTS $41.50
  • STOK $34.86
  • Average True Range (ATR)
  • CTS 1.33
  • STOK 2.77
  • MACD
  • CTS 0.46
  • STOK -0.28
  • Stochastic Oscillator
  • CTS 85.95
  • STOK 46.19

About CTS CTS Corporation

CTS Corp operates in the electronics industry. The company is a manufacturer of Sensors, Electronic components, and Actuators. It designs, manufactures, and sells a broad line of sensors, electronic components, and actuators mainly to original equipment manufacturers (OEM) for the aerospace and defense, industrial, information technology, medical, telecommunications, and transportation markets. Geographically, it derives a majority of its revenue from the United States and also has a presence in China; Singapore; the Czech Republic; Taiwan, Denmark, and other countries.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: